Clinical Trial Update: Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating neoadjuvant chemotherapy with or without metformin for HER2-positive operable breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (neoadjuvant regimen)
• metformin (metformin)

Snippet

Sponsor: Qamar Khan | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: UNKNOWN